Development of Cultured Epithelium Using β3 Integrin Subunit cDNA-Transduced Human Keratinocytes - To Improve the Take Rate -
使用 β3 整合素亚基 cDNA 转导的人角质形成细胞开发培养上皮 - 提高摄取率 -
基本信息
- 批准号:15390543
- 负责人:
- 金额:$ 9.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Analysis of in vitro cell functions with β3 cDNA-transduced human keratinocytesHuman keratinocytes transduced with β3 integrin subunit cDNA by a retrovirus-mediated transduction method expressed β3 and αvβ3 on the cell surface. The percentage of positive β3 expressed cells with the cultures of β3 cDNA-transduced keratinocytes having 20-30%, 50-60%, 70-80% and 100% confluence were 69%, 68%, 65% and 33%, respectively. On the other hand, the control β-gal cDNA-transduced keratinocytes were negative for β3 or αvβ3. The transduction of β3 integrin subunit cDNA did not affect the expression of other αv integrin complexes such as αvβ5 or αvβ6. One hour cell adhesion assays demonstrated that the β3 cDNA-transduced human keratinocytes adhered to fibrin (FB), fibrinogen (FG), vitronectin (VN), fibronectin (FN) and denatured collagen { gelatin (GEL) } significantly compared with β-galactosidase (β-gal) cDNA-transduced keratinocytes (control). Inhibition assay of the cell adhesion to FB and GEL wa … More s performed using cells which were incubated with various concentrations of monoclonal antibody to αvβ3 (LM609) or normal mouse IgG1 or alternatively with peptides GRGDSP or GRGESP for 30 min at RT before adding cells to the wells. The adhesion of the β3 cDNA-transduced human keratinocytes to FB and GEL was inhibited by the LM609 and RGD peptides in a dose-dependent fashion, but not by the normal mouse IgG1 nor RGE peptides. Five days cell growth assays showed that β3 integrin subunit cDNA-transduced keratinocytes grew on FB, FG, VN and denatured collagen (GEL) significantly more than the β-gal cDNA-transduced keratinocytes (control). The cell growth rate, calculated by the increased rate of cell numbers from one day to five days, of the β3 cDNA-transduced keratinocytes also increased on FG, FB, VN and GEL significantly more than the control. There were no differences in the cell growth on laminin, type IV collagen and type I collagen between the two groups. Furthermore, 14 hours haptotaxis migration assays revealed that the β3 cDNA-transduced keratinocytes migrated to FG, FB, GEL, VN and FN significantly more than the control cells did. Both groups of cells migrated to type I collagen to the same degree and did not migrate to BSA. A monoclonal antibody to αvβ3 (LM609) considerably inhibited the migration of the β3 cDNA-transduced keratinocytes to FG, FB, GEL, VN and FN.Thus, these data support the idea that these recombinant keratinocytes provide a method of enhancing wound healing in a graft procedure when they are applied to FB, FG and denatued collagen-rich cutanous wounds. Less
用逆转录病毒介导的方法将β3整合素亚基cDNA导入人角质形成细胞,使其在细胞表面表达β3和αvβ3。在20- 30%、50- 60%、70-80%和100%汇合时,β 3基因转染的角质形成细胞的阳性表达率分别为69%、68%、65%和33%。另一方面,对照β-gal cDNA转导的角质形成细胞对β3或αvβ3呈阴性。β3整合素亚基cDNA的转导不影响其他αv整合素复合物如αvβ5或αvβ6的表达。1小时细胞粘附试验表明,与β-半乳糖苷酶(β-gal)cDNA转导的角质形成细胞(对照)相比,β3 cDNA转导的角质形成细胞显著粘附于纤维蛋白(FB)、纤维蛋白原(FG)、玻连蛋白(VN)、纤连蛋白(FN)和变性胶原{明胶(GEL)}。细胞对FB和GEL的粘附抑制试验用MTT法进行。 ...更多信息 使用在室温下与不同浓度的抗αvβ3单克隆抗体(LM 609)或正常小鼠IgG 1或肽GRGDSP或GRGESP孵育30 min的细胞进行,然后将细胞加入威尔斯孔中。LM 609和RGD肽以剂量依赖性方式抑制β3 cDNA转导的人角质形成细胞与FB和GEL的粘附,但不被正常小鼠IgG 1和RGE肽抑制。5天细胞生长试验显示,β3整合素亚基cDNA转导的角质形成细胞在FB、FG、VN和变性胶原(GEL)上的生长显著高于β-gal cDNA转导的角质形成细胞(对照)。FG、FB、VN和GEL上β3 cDNA转导的角质形成细胞的细胞生长率(通过1天至5天的细胞数量增加率计算)也明显高于对照组。两组细胞在层粘连蛋白、IV型胶原和I型胶原上的生长无差异。14 h的趋触性迁移实验显示,转染β3 cDNA的角质形成细胞向FG、FB、GEL、VN和FN的迁移率明显高于对照细胞。两组细胞迁移到I型胶原蛋白的程度相同,并没有迁移到BSA。抗αvβ3单克隆抗体(LM 609)显著抑制β3 cDNA转导的角质形成细胞向FG、FB、GEL、VN和FN的迁移。因此,这些数据支持了这样的观点,即这些重组角质形成细胞在应用于FB、FG和变性的富含胶原蛋白的皮肤伤口时,提供了一种在移植手术中促进伤口愈合的方法。少
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gelatin Microspheres Crosslinked with γ-ray : Preparation, Sorption of Proteins, and Biodegradability.
γ 射线交联明胶微球:制备、蛋白质吸附和生物降解性。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Ken Terao 他5名
- 通讯作者:Ken Terao 他5名
形成外科ADVANCEシリーズI-3 創傷の治療 最近の進歩 第2版
整形外科 ADVANCE 系列 I-3 伤口治疗最新进展第 2 版
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:久保美代子;森口隆彦
- 通讯作者:森口隆彦
形成外科ADVANCEシリーズI-3 創傷の治療:最近の進歩 改訂第2版
整形外科 ADVANCE 系列 I-3 伤口治疗:最新进展修订版第 2 版
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:久保美代子;森口隆彦
- 通讯作者:森口隆彦
Ken Terao, 他5名: "Gelatin Microspheres Crosslinked with γ-ray : Preparation, Sorption of Proteins, and Biodegradability"Journal of Applied Polymer Science. 91. 3083-3087 (2004)
Ken Terao 等 5 人:“用 γ 射线交联的明胶微球:制备、蛋白质吸附和生物降解性”应用聚合物科学杂志 91. 3083-3087 (2004)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUBO Miyoko其他文献
KUBO Miyoko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUBO Miyoko', 18)}}的其他基金
The establishment of regenerative medicine for promoting re-epithelialization of chronic wounds -based on re-epithelialization mechanisms-
促进慢性伤口再上皮化的再生医学的建立-基于再上皮化机制-
- 批准号:
23592661 - 财政年份:2011
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Verification for the effectiveness of β3 integrin-recombinant cultured epithelium by animal experiments
动物实验验证β3整合素重组培养上皮的有效性
- 批准号:
20592112 - 财政年份:2008
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clarification of mechanisms for delayed re-epithelialization of chronic wounds -to establish treatment based on wound healing theory-
澄清慢性伤口上皮化延迟的机制-建立基于伤口愈合理论的治疗-
- 批准号:
17591882 - 财政年份:2005
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Alteration of Integrin Expression in Migrating Epidermal Cells and Analysis of Extracellular Matrix Proteins in the Dermis with Chronic Wounds
慢性伤口迁移表皮细胞整合素表达的改变和真皮细胞外基质蛋白的分析
- 批准号:
13671890 - 财政年份:2001
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
αvβ3整合素靶向有机探针用于NIR-II FL/MRI双模态成像引导的三阴性乳腺癌光热治疗研究
- 批准号:2025JJ81013
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
V3+/Cr4+/Mn5+激活的NIR-II发光材料的结构设计、价态稳定及性能优化研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于靶向整合素αvβ3的MPI/PET多模态成像技术在NASH早期纤维化中的可视化诊疗研究
- 批准号:82372144
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
ANGPTL3通过整合素αVβ3促进巨噬细胞炎性功能加重动脉粥样硬化的机制
- 批准号:82370826
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
整合素αVβ3介导USC-Exos在股骨头坏死区域的富集机制及疗效研究
- 批准号:2023JJ30872
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
细胞外基质通过整合素αvβ3调控GSDMD介导的细胞焦亡通路在原始卵泡激活中的作用和机制研究
- 批准号:82301849
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于EGFR/αvβ3双靶点调控细胞外基质的载药纳米探针对胰腺癌精准诊疗研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
外泌体Integrin αvβ3调控肝星状细胞的活化促进结肠癌肝转移的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MFGE8通过整合素αvβ3/FAK通路抑制克罗恩病肠道纤维化的功能和机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
缺氧应激经HIF-1 α/EGFL7/整合素 αv β 3 轴调控骨肉瘤病理性血管生成的机制研究
- 批准号:2022JJ30075
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Integrin αvβ3 preclinical PET imaging to detect early stage NASH and treatment response
整合素αvβ3 临床前 PET 成像检测早期 NASH 和治疗反应
- 批准号:
10630367 - 财政年份:2022
- 资助金额:
$ 9.47万 - 项目类别:
Integrin αvβ3 preclinical PET imaging to detect early stage NASH and treatment response
整合素αvβ3 临床前 PET 成像检测早期 NASH 和治疗反应
- 批准号:
10449428 - 财政年份:2022
- 资助金额:
$ 9.47万 - 项目类别:
αvβ3-induced epithelial cancer progression via macrophage recruitment
通过巨噬细胞募集αvβ3 诱导上皮癌进展
- 批准号:
10391529 - 财政年份:2021
- 资助金额:
$ 9.47万 - 项目类别:
αvβ3-induced epithelial cancer progression via macrophage recruitment
通过巨噬细胞募集αvβ3 诱导上皮癌进展
- 批准号:
10189939 - 财政年份:2021
- 资助金额:
$ 9.47万 - 项目类别:
αvβ3-induced epithelial cancer progression via macrophage recruitment
通过巨噬细胞募集αvβ3 诱导上皮癌进展
- 批准号:
10611927 - 财政年份:2021
- 资助金额:
$ 9.47万 - 项目类别:
Development of clinically available cyclic peptide-modified liposomes for cancer treatment
开发临床可用的环肽修饰脂质体用于癌症治疗
- 批准号:
19K16337 - 财政年份:2019
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The immune-metabolic basis of the DEL-1/αvβ3 integrin-dependent induction of resolving macrophages in the resolution of inflammatory arthritis (C07*)
DEL-1/αvβ3 整合素依赖性诱导巨噬细胞在炎症关节炎消退中的免疫代谢基础 (C07*)
- 批准号:
430193679 - 财政年份:2019
- 资助金额:
$ 9.47万 - 项目类别:
Collaborative Research Centres
Development of a novel targeted internal radiotherapy strategy by co-targeting of cancer cell integrin, angiogenesis, and hypoxic environment
通过共同靶向癌细胞整合素、血管生成和缺氧环境,开发新型靶向内部放射治疗策略
- 批准号:
18K07776 - 财政年份:2018
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Nuclear medicine imaging toward therapeutic strategy of atherosclerosis: Experimental research to establish EBM
核医学成像对动脉粥样硬化治疗策略的影响:建立EBM的实验研究
- 批准号:
26293268 - 财政年份:2014
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of immuno-stimulatory antibody therapy against cancer
开发针对癌症的免疫刺激抗体疗法
- 批准号:
22240089 - 财政年份:2010
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (A)